227 related articles for article (PubMed ID: 28264876)
41. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
[TBL] [Abstract][Full Text] [Related]
42. Sex/Gender Differences in Cotinine Levels Among Daily Smokers in the Pennsylvania Adult Smoking Study.
Chen A; Krebs NM; Zhu J; Sun D; Stennett A; Muscat JE
J Womens Health (Larchmt); 2017 Nov; 26(11):1222-1230. PubMed ID: 28872928
[TBL] [Abstract][Full Text] [Related]
43. Longitudinal Influence of Pregnancy on Nicotine Metabolic Pathways.
Taghavi T; Arger CA; Heil SH; Higgins ST; Tyndale RF
J Pharmacol Exp Ther; 2018 Feb; 364(2):238-245. PubMed ID: 29158210
[TBL] [Abstract][Full Text] [Related]
44. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.
Zhu AZ; Renner CC; Hatsukami DK; Swan GE; Lerman C; Benowitz NL; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):708-18. PubMed ID: 23371292
[TBL] [Abstract][Full Text] [Related]
45. Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women.
Kim I; Wtsadik A; Choo RE; Jones HE; Huestis MA
J Anal Toxicol; 2005 Oct; 29(7):689-95. PubMed ID: 16419402
[TBL] [Abstract][Full Text] [Related]
46. Study on the daily
Yang J; Hashemi S; Han W; Lee C; Song Y; Lim Y
Biomarkers; 2021 Dec; 26(8):691-702. PubMed ID: 34530669
[TBL] [Abstract][Full Text] [Related]
47. A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites.
St Charles FK; Krautter GR; Dixon M; Mariner DC
Psychopharmacology (Berl); 2006 Dec; 189(3):345-54. PubMed ID: 17028908
[TBL] [Abstract][Full Text] [Related]
48. Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.
Benowitz NL; Dains KM; Dempsey D; Wilson M; Jacob P
Nicotine Tob Res; 2011 Sep; 13(9):772-83. PubMed ID: 21546441
[TBL] [Abstract][Full Text] [Related]
49. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.
Ross KC; Gubner NR; Tyndale RF; Hawk LW; Lerman C; George TP; Cinciripini P; Schnoll RA; Benowitz NL
Pharmacol Biochem Behav; 2016 Sep; 148():1-7. PubMed ID: 27180107
[TBL] [Abstract][Full Text] [Related]
50. Patterns of cigarette consumption and cotinine levels among African American women smokers.
Ahijevych KL; Wewers ME
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1229-33. PubMed ID: 7952545
[TBL] [Abstract][Full Text] [Related]
51. N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases.
Ghosheh O; Hawes EM
Drug Metab Dispos; 2002 Sep; 30(9):991-6. PubMed ID: 12167564
[TBL] [Abstract][Full Text] [Related]
52. Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.
Cox LS; Nollen NL; Mayo MS; Choi WS; Faseru B; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS
J Natl Cancer Inst; 2012 Feb; 104(4):290-8. PubMed ID: 22282543
[TBL] [Abstract][Full Text] [Related]
53. Estimation and correlation of cigarette smoke exposure in Canadian smokers as determined by filter analysis and biomarkers of exposure.
Morin A; Shepperd CJ; Eldridge AC; Poirier N; Voisine R
Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S3-12. PubMed ID: 20937342
[TBL] [Abstract][Full Text] [Related]
54. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
[TBL] [Abstract][Full Text] [Related]
55. Utility and relationships of biomarkers of smoking in African-American light smokers.
Ho MK; Faseru B; Choi WS; Nollen NL; Mayo MS; Thomas JL; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3426-34. PubMed ID: 19959692
[TBL] [Abstract][Full Text] [Related]
56. Nicotine metabolism and intake in black and white smokers.
Pérez-Stable EJ; Herrera B; Jacob P; Benowitz NL
JAMA; 1998 Jul; 280(2):152-6. PubMed ID: 9669788
[TBL] [Abstract][Full Text] [Related]
57. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey.
Jarvis MJ; Boreham R; Primatesta P; Feyerabend C; Bryant A
J Natl Cancer Inst; 2001 Jan; 93(2):134-8. PubMed ID: 11208883
[TBL] [Abstract][Full Text] [Related]
58. Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.
Fogli S; Saba A; Del Re M; Pistelli F; Aquilini F; Zucchi R; Palla A; Breschi MC; Carrozzi L; Danesi R
J Pharm Biomed Anal; 2016 Nov; 131():208-213. PubMed ID: 27599351
[TBL] [Abstract][Full Text] [Related]
59. The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine.
Binnie V; McHugh S; Macpherson L; Borland B; Moir K; Malik K
Oral Dis; 2004 Sep; 10(5):287-93. PubMed ID: 15315646
[TBL] [Abstract][Full Text] [Related]
60. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
